Company: GANX
Filing Date: 2025-01-07
Form Type: 8-K
Source: 0001104659-25-001711
Chunk: 0

Company: Gain Therapeutics, Inc.
Filing Date: 2025-01-07
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01      Regulation FD Disclosure.  

On January 7, 2025, the Company
issued a press release announcing Messrs. Mack and Fuggetta’s appointments, which press release is attached hereto as Exhibit 99.1
and is incorporated by reference herein.

The information in this Current
Report on Form 8-K under Item 7.01, including the information contained in Exhibit 99.1, is being furnished to the SEC, and shall not
be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange
Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any
filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by a specific reference
in such filing.